Predictive value of early molecular response to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia

被引:0
|
作者
Abdallah, Aya M. [1 ]
Hafez, Hanafy [1 ,2 ]
Madney, Youssef [1 ,2 ]
Ahmed, Sonia [1 ,2 ]
Yassin, Dina [3 ,4 ]
Salem, Sherine [3 ,4 ]
Yousry, Rodina [5 ]
Abdel-Azim, Hisham [6 ]
Lehmann, Leslie [7 ]
Elhaddad, Alaa [1 ,2 ]
机构
[1] Childrens Canc Hosp Egypt CCHE 57357, Dept Pediat Oncol, Cairo, Egypt
[2] Cairo Univ, Natl Canc Inst, Dept Pediat Oncol, Cairo, Egypt
[3] Childrens Canc Hosp Egypt CCHE 57357, Dept Clin Pathol, Cairo, Egypt
[4] Cairo Univ, Natl Canc Inst, Dept Clin Pathol, Cairo, Egypt
[5] Childrens Canc Hosp CCHE 57357, Dept Res, Cairo, Egypt
[6] Loma Linda Univ, Children Hosp & Med Ctr, Ctr Canc, Loma Linda, CA USA
[7] Dana Farber Canc Inst, Pediat Stem Cell Transplantat Unit, Boston, MA 02115 USA
关键词
Chronic myeloid leukemia; tyrosine kinase inhibitors; children; BCR-ABL;
D O I
10.1080/10428194.2024.2331625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1024 / 1027
页数:4
相关论文
共 50 条
  • [1] Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients
    Ismail, Mohamed A.
    Vezzalini, Marzia
    Morsi, Hisham
    Abujaber, Ahmad
    Al Sayab, Ali
    Siveen, Kodappully
    Yassin, Mohamed A.
    Monne, Maria
    Samara, Muthanna
    Cook, Richard
    Sorio, Claudio
    Modjtahedi, Helmout
    Al-Dewik, Nader, I
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [2] Predictive value of tyrosine phosphatase receptor gamma for the response to treatment tyrosine kinase inhibitors in chronic myeloid leukemia patients
    Mohamed A. Ismail
    Marzia Vezzalini
    Hisham Morsi
    Ahmad Abujaber
    Ali Al Sayab
    Kodappully Siveen
    Mohamed A. Yassin
    Maria Monne
    Muthanna Samara
    Richard Cook
    Claudio Sorio
    Helmout Modjtahedi
    Nader I. Al-Dewik
    Scientific Reports, 11
  • [3] Prognostic significance of early molecular response in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
    Yeung, David T.
    Mauro, Michael J.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 240 - 243
  • [4] Assessment of molecular response to tyrosine kinase inhibitors in Tunisian Patients with Chronic Myeloid Leukemia
    Frikha, Rim
    Kassar, Olfa
    Elloumi, Moez
    Kamoun, Hassen
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1826 - 1831
  • [5] Not Only Response but Early Response to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (03) : 223 - 224
  • [6] Skin reactions to tyrosine kinase inhibitors in pediatric patients with chronic myeloid leukemia
    Toker, Michelle
    Jaller, Jose A.
    Delbourgo Patton, Caroline
    Wu, Benedict
    PEDIATRIC DERMATOLOGY, 2024, 41 (01) : 169 - 176
  • [7] Discontinuation of tyrosine kinase inhibitors in pediatric chronic myeloid leukemia
    Shima, Haruko
    Kada, Akiko
    Tanizawa, Akihiko
    Sato, Iori
    Tono, Chikako
    Ito, Masaki
    Yuza, Yuki
    Watanabe, Akihiro
    Kamibeppu, Kiyoko
    Uryu, Hideko
    Koh, Katsuyoshi
    Imai, Chihaya
    Yoshida, Nao
    Koga, Yuhki
    Fujita, Naoto
    Saito, Akiko M.
    Adachi, Souichi
    Ishii, Eiichi
    Shimada, Hiroyuki
    PEDIATRIC BLOOD & CANCER, 2022, 69 (08)
  • [8] The Applicability of Tyrosine Kinase Inhibitors in Pediatric Chronic Myeloid Leukemia
    Ata, Fateen
    Ghasoub, Rola
    Benkhadra, Maria
    Fernyhough, Liam
    Aldapt, Mahmood
    Omar, Nabil E.
    Nashwan, Abdulqadir
    Mushtaq, Kamran
    Yassin, Mohamed A.
    BLOOD, 2023, 142
  • [9] IMPACT OF DOSE REDUCTION OF TYROSINE KINASE INHIBITORS IN THE MOLECULAR RESPONSE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Saez Perdomo, M. N.
    Gonzalez Perez, E.
    Luzardo, H.
    Gonzalez Brito, G.
    Gonzalez San Miguel, J. D.
    Afonso, V
    Gordillo, M.
    Herranz, N.
    Tapia, M.
    Bilbao, C.
    Gomez Casares, M. T.
    HAEMATOLOGICA, 2017, 102 : 279 - 280
  • [10] EARLY PREDICTION OF THE MOLECULAR RESPONSE TO BCR-ABL1 TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
    Noh, H.
    Choi, S. -Y.
    Song, H. -Y.
    Kim, S. -H.
    Jung, S. Y.
    Yang, S.
    Lee, W. -S.
    Kim, H. -J.
    Kong, J. H.
    Kim, H.
    Do, Y. R.
    Kwak, J. -Y.
    Oh, S.
    Kim, S. H.
    Kim, J. -A.
    Zang, D. Y.
    Mun, Y. -C.
    Won, Y. -W.
    Lee, S. -E.
    Kim, D. -W.
    Lee, J.
    HAEMATOLOGICA, 2017, 102 : 76 - 76